Kun for helsepersonell
OPDIVO is administered as IV infusion over 30 minutes or subcutaneously over 3 – 5 minutes, followed by fluoropyrimidine- and platinum-containing chemotherapy on the same day.
Choice of two dosing options: q2w or q4w.
In patients who received OPDIVO in combination with chemotherapy and in whom either fluorouracil and/or cisplatin were discontinued, other components of the treatment regimen were allowed to be continued.
Treat until disease progression or unacceptable toxicity, or up to 2 years.
Reference:
7356-NO-2500069 / Developed 11.11.2025